CPC A61K 47/6901 (2017.08) [A61K 39/12 (2013.01); A61K 41/0057 (2013.01); A61K 41/0071 (2013.01); A61K 47/64 (2017.08); A61N 5/062 (2013.01); C07K 1/13 (2013.01); C07K 14/025 (2013.01); C07K 16/084 (2013.01); C07K 16/32 (2013.01); C12N 7/00 (2013.01); A61K 2039/545 (2013.01); A61K 2039/585 (2013.01); C07K 2317/33 (2013.01); C07K 2317/76 (2013.01); C12N 2710/20023 (2013.01); C12N 2710/20033 (2013.01); C12N 2710/20034 (2013.01)] | 20 Claims |
1. A method, comprising
administering to an ocular tumor in an eye of a subject a viral-like nanoparticle that comprises human papilloma virus capsid proteins and photosensitizer molecules, wherein the photosensitizer molecules are conjugated to capsid proteins of the viral-like nanoparticle; and
exposing the viral-like nanoparticle to a wavelength of light that activates cytotoxicity of the photosensitizer molecules.
|